4
Changes in Ownership
PTC THERAPEUTICS, INC. Filed Acc 0001578852-26-000002
EXEC. VP AND CLO sold 2,266 shares at an average $75.55 ($171,192)
- EXEC. VP AND CLO acquired 2,266 shares (option exercise)
- EXEC. VP AND CLO acquired 17,000 shares (grant or award)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Boulding Mark Elliott · EXEC. VP AND CLO
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-01-02 | Grant or award : show line 1 in the form 10b5-1 | +17,000 | 120,901 | D | ||
| 2026-01-05 | Exercise or conversion : show line 2 in the form 10b5-1 | +2,266 | $39.42 | $89,326 | 123,167 | D |
| 2026-01-05 | Sale : show line 3 in the form 10b5-1 | −1,123 | $74.92 | $84,135 | 122,044 | D |
| 2026-01-05 | Sale : show line 4 in the form 10b5-1 | −1,035 | $76.10 | $78,764 | 121,009 | D |
| 2026-01-05 | Sale : show line 5 in the form 10b5-1 | −108 | $76.79 | $8,293 | 120,901 | D |
| Open-market sales · 2,266 sh · avg $75.55 · $171,192 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-01-02 | Grant or award : show line 6 in the form 10b5-1 Stock Option (Right to Buy) | +42,500 | 42,500 | D |
| 2026-01-05 | Exercise or conversion : show line 7 in the form 10b5-1 Stock Option (Right to Buy) | −2,266 | 9,063 | D |
Loading xslF345X05/form4-01062026_050119.xml…